En esta página
01GALT precio
02Instantánea
03Gráfico
04Divisiones de acciones
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
26Mis Métricas
GALT Galectin Therapeutics Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 14, 2026
$3,90
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$2,03mínimo 52 semanas
$7,03máximo 52 semanas
Capitalización Bursátil (MRQ)
$259M
P/E
-8.1
BPA
$-0.48
tus insignias
Rango 52S
$2–$7
Calificación del Analista
BUY
Precio Objetivo
$11
P/E
-8.1
ROE
25.0%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
GALT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$3.90
Capitalización Bursátil (MRQ)
$259M
P/E
-8.1
BPA
$-0.48
ROE
25.0%
Rango 52S
$2–$7
GALT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Divisiones de acciones
| Fecha ex-dividendo | División | Tipo |
|---|---|---|
| 23 de marzo de 2012 | 1-for-6 | Inversa |
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-0.482020-12-31 → 2025-12-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | GALT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -8.1promedio 5A ≈-4.2 | ≈-4.2 | · | · | |
| P/C (MRQ) | -1.9promedio 5A ≈32.9 | ≈32.9 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -10.7promedio 5A ≈-5.4 | ≈-5.4 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | GALT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -166.6%promedio 5A ≈-135.2% | ≈-135.2% | -52.1% | Débil | |
| ROE | 25.0%promedio 5A ≈-123.7% | ≈-123.7% | -58.3% | De primer nivel |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | GALT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 0.1promedio 5A ≈2.6 | ≈2.6 | 4.5 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 2.2promedio 5A ≈2.4 | ≈2.4 | 2.4 | Baja liquidez |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Sorpresa Media
-5.9%
Próximo informe
Nov 12, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 30 de junio de 2026 | Ago 14, 2026 | $-0.14 | $-0.09 | -52.5% |
| 31 de marzo de 2026 | May 15, 2026 | $-0.08 | $-0.06 | -30.7% |
| 31 de diciembre de 2025 | $-0.08 | $-0.10 | 21.6% | |
| 30 de septiembre de 2025 | $-0.13 | $-0.11 | -15.9% | |
| 30 de junio de 2025 | $-0.12 | $-0.16 | 26.5% | |
| 31 de marzo de 2025 | $-0.15 | $-0.20 | 26.5% | |
| 31 de diciembre de 2024 | $-0.19 | $-0.16 | -16.4% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $14M | $37M | $32M | $32M | $24M | $18M | $7M | $6M | $12M | $15M | $13M | $8M | |
| SG&A Expense | $6M | $6M | $6M | $7M | $6M | $5M | $6M | $7M | $5M | $6M | $7M | $7M | |
| Operating Expenses | $20M | $42M | $38M | $38M | $30M | $23M | $13M | $14M | $16M | $21M | $20M | $15M | |
| Operating Income | $-20M | $-42M | $-38M | $-38M | $-30M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-15M | |
| Interest Expense | · | · | $3M | $1M | $489.0K | $87.0K | $87.0K | $336.0K | $12.0K | · | · | · | |
| Interest Income | $126.0K | $338.0K | $230.0K | $52.0K | $3.0K | $66.0K | $231.0K | $38.0K | $24.0K | $45.0K | $52.0K | $42.0K | |
| Other Non-op | $-11M | $-5M | $-3M | $-424.0K | $-348.0K | $-21.0K | $144.0K | $-298.0K | $12.0K | $45.0K | $52.0K | $-358.0K | |
| Income Tax | $0 | $0 | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $-31M | $-47M | $-41M | $-39M | $-31M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-16M | |
| EPS (Basic) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · | |
| Shares (Basic) | 63,903,000 | 62,309,000 | 60,159,000 | 59,391,000 | 58,527,000 | 57,029,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 63,903,000 | 62,309,000 | 60,159,000 | 59,391,000 | 58,527,000 | 57,029,000 | · | · | · | · | · | · | |
| EBITDA | $-20M | · | $-38M | $-38M | $-30M | $-23M | $-13M | $-14M | · | · | · | $-15M |
Balance general
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $18M | $15M | $26M | $19M | $40M | $27M | $47M | $8M | $3M | $15M | $26M | $29M | |
| Prepaid Expense | $2M | $2M | $2M | $2M | $2M | $2M | $729.0K | $579.0K | $766.0K | $432.0K | $554.0K | $533.0K | |
| Current Assets | $19M | $17M | $28M | $21M | $42M | $29M | $48M | $9M | $4M | $16M | $26M | $30M | |
| PP&E (Net) | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $1.0K | |
| PP&E (Gross) | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | |
| Accum. Depreciation | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $74.0K | $73.0K | |
| Intangibles | · | · | · | · | · | · | · | $0 | $0 | $1.0K | $8.0K | $15.0K | |
| Other Non-current Assets | $96.0K | $243.0K | $490.0K | $733.0K | $7.0K | $135.0K | $258.0K | $174.0K | $342.0K | · | · | · | |
| Total Assets | $20M | $17M | $28M | $21M | $42M | $30M | $48M | $9M | $4M | $16M | $26M | $30M | |
| Accounts Payable | $3M | $6M | $6M | $4M | $2M | $1M | $2M | $297.0K | $608.0K | $910.0K | $448.0K | $906.0K | |
| Accrued Liabilities | $5M | $8M | $9M | $9M | $7M | $4M | $1M | $2M | $2M | $3M | $845.0K | $729.0K | |
| Current Liabilities | $8M | $35M | $16M | $13M | $9M | $5M | $3M | $2M | $3M | $4M | $1M | $2M | |
| Capital Leases | · | · | $20.0K | $66.0K | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | $0 | · | $20.0K | $66.0K | $0 | $8.0K | $52.0K | $0 | · | · | · | $0 | |
| Total Liabilities | $146M | $121M | $88M | $53M | $39M | $5M | $3M | $2M | $3M | $4M | $1M | $2M | |
| Common Stock | $65.0K | $62.0K | $61.0K | $59.0K | $59.0K | $56.0K | $56.0K | $41.0K | $36.0K | $33.0K | $28.0K | $22.0K | |
| Paid-in Capital | $304M | $296M | $292M | $275M | $271M | $262M | $260M | $194M | $173M | $167M | $158M | $140M | |
| Retained Earnings | $-433M | $-402M | $-354M | $-310M | $-271M | $-240M | $-216M | $-196M | $-181M | $-164M | $-140M | $-119M | |
| Stockholders' Equity | $-128M | $-105M | $-62M | $-34M | $893.0K | $22M | $44M | $5M | $-530.0K | $10M | $18M | $21M | |
| Liabilities + Equity | $20M | $17M | $28M | $21M | $42M | $30M | $48M | $9M | $4M | $16M | $26M | $30M | |
| Shares Outstanding | 65,201,995 | 63,157,235 | 61,852,914 | 59,426,005 | 59,341,305 | 57,077,055 | 56,894,642 | 41,190,905 | 35,789,388 | 32,912,942 | 28,825,033 | 22,277,283 |
Flujo de Efectivo
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $1.0K | $7.0K | $7.0K | $10.0K | |
| Stock-based Comp | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $1M | $2M | $3M | $4M | |
| Amort. of Intangibles | · | · | · | · | · | · | · | $0 | $1.0K | $7.0K | $7.0K | $8.0K | |
| Other Non-cash | · | · | · | · | · | · | · | $-724.0K | · | · | · | $-718.0K | |
| Operating Cash Flow | $-24M | $-42M | $-33M | $-31M | $-24M | $-21M | $-11M | $-10M | $-16M | $-16M | $-17M | $-12M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | · | $0 | $0 | · | · | · | |
| Stock Issued | $3M | $0 | · | $0 | $7M | $263.0K | $50M | $15M | $4M | $6M | $14M | $29M | |
| Net Stock Activity | $3M | · | · | $0 | $7M | $263.0K | $50M | $15M | · | · | · | $29M | |
| Financing Cash Flow | $26M | $31M | $40M | $10M | $37M | $263.0K | $50M | $15M | $4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | $5M | $-12M | $-10M | $-3M | $19M |
Rentabilidad
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -166.6% | · | -166.0% | -122.9% | -85.5% | -60.1% | -46.3% | -211.1% | · | · | · | -78.2% | |
| ROE | 25.0% | · | 71.7% | 133.8% | -725.2% | -89.8% | -29.0% | -223.8% | · | · | · | -139.2% |
Liquidez y Solvencia
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.4 | · | 1.8 | 1.6 | 4.6 | 5.5 | 17.1 | 4.2 | · | · | · | 17.4 | |
| Quick Ratio | 2.2 | · | 1.6 | 1.4 | 4.4 | 5.0 | 16.8 | 3.9 | · | · | · | 17.1 | |
| Interest Coverage | · | · | -13.6 | -37.1 | -61.7 | -269.5 | -154.5 | -40.5 | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-1.96 | · | $-1.00 | $-0.57 | $0.01 | $0.39 | $0.77 | $0.13 | · | · | · | $0.95 | |
| Cash Flow / Share | $-0.37 | · | $-0.55 | $-0.52 | $-0.42 | · | · | · | · | · | · | · | |
| Cash / Share | $0.27 | · | $0.41 | $0.31 | $0.67 | $0.48 | $0.83 | $0.20 | · | · | · | $1.31 | |
| EPS (TTM) | $-0.48 | · | $-0.74 | $-0.65 | $-0.52 | $-0.41 | · | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-31M | · | $-41M | $-39M | $-31M | $-23M | $-13M | $-14M | $-16M | $-21M | $-20M | $-16M | |
| Market Cap | $271M | · | $103M | $67M | $123M | $128M | $163M | $141M | · | · | · | $77M | |
| P/E | -8.7 | · | -2.2 | -1.7 | -4.0 | -5.5 | · | · | · | · | · | · | |
| P/B | -2.1 | · | -1.7 | -2.0 | 137.6 | 5.7 | 3.7 | 27.3 | · | · | · | 3.6 | |
| P / Tangible Book | · | · | · | · | 137.6 | 5.7 | · | · | · | · | · | · | |
| P / Cash Flow | -11.4 | · | -3.1 | -2.2 | -5.1 | -6.2 | -15.0 | -13.9 | · | · | · | -6.2 | |
| Earnings Yield | -11.5% | · | -44.6% | -57.5% | -25.1% | -18.3% | · | · | · | · | · | · |
Estado de resultados
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $2M | $2M | $3M | $3M | $6M | $11M | $8M | $10M | $8M | $8M | $8M | $7M | $9M | $9M | $7M | |
| SG&A Expense | $2M | $2M | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $2M | $2M | $2M | $2M | |
| Operating Expenses | $4M | $4M | $3M | $4M | $5M | $8M | $12M | $9M | $11M | $10M | $10M | $9M | $9M | $10M | $11M | $8M | |
| Operating Income | $-4M | $-4M | $-3M | $-4M | $-5M | $-8M | $-12M | $-9M | $-11M | $-10M | $-10M | $-9M | $-9M | $-10M | $-11M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $1M | $847.0K | $835.0K | $650.0K | $460.0K | $308.0K | $269.0K | |
| Interest Income | $28.0K | $36.0K | $26.0K | $39.0K | $26.0K | $35.0K | $85.0K | $93.0K | $80.0K | $80.0K | $74.0K | $62.0K | $50.0K | $44.0K | $30.0K | $18.0K | |
| Other Non-op | $-5M | $-969.0K | $-2M | $-4M | $-3M | $-2M | $461.0K | $-2M | $-1M | $-2M | $-436.0K | $-1M | $-111.0K | $-1M | $-1.0K | $-475.0K | |
| Net Income | $-9M | $-5M | $-6M | $-8M | $-8M | $-10M | $-12M | $-11M | $-12M | $-11M | $-10M | $-10M | $-9M | $-12M | $-11M | $-9M | |
| EPS (Basic) | $-0.14 | $-0.08 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.18 | $-0.20 | $-0.19 | $-0.16 | $-0.24 | $-0.15 | $-0.19 | $-0.18 | $-0.14 | |
| EPS (Diluted) | $-0.14 | $-0.08 | $-0.08 | $-0.13 | $-0.12 | $-0.15 | $-0.19 | $-0.18 | $-0.20 | $-0.19 | $-0.16 | $-0.24 | $-0.15 | $-0.19 | $-0.18 | $-0.14 | |
| Shares (Basic) | 65,875,000 | 65,782,000 | · | 64,205,000 | 63,447,000 | 63,204,000 | · | 62,278,000 | 62,233,000 | 61,976,000 | · | 59,704,000 | 59,582,000 | 59,480,000 | · | 59,396,000 | |
| Shares (Diluted) | 65,875,000 | 65,782,000 | · | 64,205,000 | 63,447,000 | 63,204,000 | · | 62,278,000 | 62,233,000 | 61,976,000 | · | 59,704,000 | 59,582,000 | 59,480,000 | · | 59,396,000 | |
| EBITDA | $-4M | $-4M | · | $-4M | $-5M | $-8M | · | $-9M | $-11M | $-10M | · | $-9M | $-9M | $-10M | · | $-8M |
Balance general
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $13M | $14M | $18M | $12M | $14M | $7M | $15M | $27M | $26M | $24M | $26M | $20M | $18M | $18M | $19M | $16M | |
| Prepaid Expense | $1M | $2M | $2M | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | $2M | $2M | $1M | |
| Current Assets | $15M | $16M | $19M | $13M | $15M | $9M | $17M | $29M | $27M | $25M | $28M | $22M | $19M | $20M | $21M | $17M | |
| PP&E (Net) | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | · | · | $0 | · | |
| PP&E (Gross) | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | |
| Accum. Depreciation | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | · | · | $74.0K | · | |
| Other Non-current Assets | $167.0K | $68.0K | $96.0K | $136.0K | $175.0K | $243.0K | $243.0K | $306.0K | $368.0K | $430.0K | $490.0K | $552.0K | $613.0K | $673.0K | $733.0K | $793.0K | |
| Total Assets | $15M | $16M | $20M | $13M | $16M | $10M | $17M | $29M | $28M | $26M | $28M | $22M | $20M | $20M | $21M | $18M | |
| Accounts Payable | $4M | $3M | $3M | $5M | $6M | $7M | $6M | $3M | $4M | $4M | $6M | $3M | $2M | $3M | $4M | $2M | |
| Accrued Liabilities | $4M | $4M | $5M | $5M | $5M | $7M | $8M | $12M | $11M | $9M | $9M | $8M | $8M | $9M | $9M | $7M | |
| Current Liabilities | $152M | $7M | $8M | $136M | $11M | $111M | $35M | $25M | $15M | $13M | $16M | $11M | $10M | $12M | $13M | $10M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | $7.0K | $20.0K | $32.0K | $43.0K | $55.0K | $66.0K | $77.0K | |
| Other Non-current Liabilities | $59.0K | · | · | · | · | · | · | $0 | $0 | $7.0K | $20.0K | $32.0K | $44.0K | $55.0K | $66.0K | $77.0K | |
| Total Liabilities | $152M | $146M | $146M | $136M | $133M | $122M | $121M | $121M | $110M | $97M | $88M | $73M | $71M | $63M | $53M | $40M | |
| Common Stock | $66.0K | $65.0K | $65.0K | $64.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $61.0K | $61.0K | $61.0K | $59.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $308M | $305M | $304M | $301M | $299M | $297M | $296M | $295M | $294M | $292M | $292M | $291M | $277M | $276M | $275M | $274M | |
| Retained Earnings | $-447M | $-438M | $-433M | $-427M | $-419M | $-411M | $-402M | $-390M | $-378M | $-366M | $-354M | $-344M | $-330M | $-321M | $-310M | $-299M | |
| Stockholders' Equity | $-139M | $-132M | $-128M | $-125M | $-119M | $-114M | $-105M | $-94M | $-84M | $-73M | $-62M | $-53M | $-53M | $-44M | $-34M | $-24M | |
| Liabilities + Equity | $15M | $16M | $20M | $13M | $16M | $10M | $17M | $29M | $28M | $26M | $28M | $22M | $20M | $20M | $21M | $18M | |
| Shares Outstanding | 66,311,910 | 65,856,898 | 65,201,995 | 64,472,792 | 64,060,262 | 63,291,585 | 63,157,235 | 62,308,075 | 62,278,125 | 62,148,134 | 61,852,914 | 61,848,657 | 59,582,253 | 59,582,253 | 59,426,005 | 59,426,005 |
Flujo de Efectivo
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $963.0K | $686.0K | $195.0K | $496.0K | $500.0K | $468.0K | $590.0K | $515.0K | $738.0K | $604.0K | $497.0K | $586.0K | $516.0K | $662.0K | $681.0K | $681.0K | |
| Operating Cash Flow | $-2M | $-4M | $-6M | $-4M | $-7M | $-8M | $-13M | $-9M | $-8M | $-12M | $-5M | $-8M | $-10M | $-11M | $-7M | $-8M | |
| Stock Issued | · | · | $1M | $853.0K | · | · | $0 | $0 | · | · | · | · | · | · | · | $0 | |
| Financing Cash Flow | $2M | $257.0K | $12M | $1M | $13M | $0 | $851.0K | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $10M | $0 |
Rentabilidad
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -59.9% | -39.9% | · | -39.1% | -34.8% | -54.4% | · | -43.9% | -51.8% | -49.8% | · | -52.0% | -39.6% | -42.8% | · | -30.7% | |
| ROE | 7.1% | 4.1% | · | 7.5% | 7.4% | 10.3% | · | 15.3% | 18.1% | 19.6% | · | 27.2% | 26.1% | 44.1% | · | 104.0% |
Liquidez y Solvencia
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | 2.1 | · | 0.1 | 1.4 | 0.1 | · | 1.1 | 1.9 | 2.0 | · | 2.1 | 2.0 | 1.7 | · | 1.8 | |
| Quick Ratio | 0.1 | 1.9 | · | 0.1 | 1.3 | 0.1 | · | 1.1 | 1.8 | 1.9 | · | 1.9 | 1.8 | 1.5 | · | 1.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -9.2 | · | -11.0 | -13.9 | -22.5 | · | -30.2 |
Por Acción
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-2.09 | $-2.00 | · | $-1.94 | $-1.86 | $-1.80 | · | $-1.51 | $-1.35 | $-1.17 | · | $-0.85 | $-0.89 | $-0.74 | · | $-0.40 | |
| Cash Flow / Share | · | $-0.06 | · | · | · | $-0.12 | · | · | · | $-0.20 | · | · | · | $-0.18 | · | · | |
| Cash / Share | $0.20 | $0.21 | · | $0.18 | $0.21 | $0.12 | · | $0.43 | $0.41 | $0.38 | · | $0.33 | $0.30 | $0.30 | · | $0.27 | |
| EPS (TTM) | $-0.43 | $-0.41 | · | $-0.59 | $-0.64 | $-0.72 | · | $-0.73 | $-0.79 | $-0.74 | · | $-0.76 | $-0.66 | $-0.67 | · | $-0.59 |
Valoración (TTM)
| Métrica | Tendencia | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | $-26M | · | $-37M | $-40M | $-45M | · | $-45M | $-44M | $-41M | · | $-42M | $-40M | $-40M | · | $-35M | |
| Market Cap | $308M | $184M | · | $273M | $135M | $77M | · | $171M | $141M | $149M | · | $119M | $86M | $125M | · | $97M | |
| P/E | -10.8 | -6.8 | · | -7.2 | -3.3 | -1.7 | · | -3.8 | -2.9 | -3.2 | · | -2.5 | -2.2 | -3.1 | · | -2.8 | |
| P/B | -2.2 | -1.4 | · | -2.2 | -1.1 | -0.7 | · | -1.8 | -1.7 | -2.0 | · | -2.3 | -1.6 | -2.8 | · | -4.0 | |
| P / Cash Flow | · | -47.5 | · | · | · | -10.0 | · | · | · | -12.3 | · | · | · | -11.6 | · | · | |
| Earnings Yield | -9.3% | -14.7% | · | -13.9% | -30.3% | -59.0% | · | -26.6% | -35.0% | -31.0% | · | -39.6% | -45.8% | -31.9% | · | -36.2% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-31M | $-47M | $-41M | $-39M | $-31M |
| EPS Diluido | $-0.48 | $-0.76 | $-0.74 | $-0.65 | $-0.52 |
| Métrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ratio corriente | 2.4 | · | 1.8 | 1.6 | 4.6 |
| Ratio Rápido | 2.2 | · | 1.6 | 1.4 | 4.4 |
No hay datos para este estado
Aún no hay suficientes datos fundamentales para generar este estado.
Propietarios institucionales (13F) 109 declarantes · $87.3M total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
109
Valor en tenencia
$87.3M
Nuevas posiciones
21
Posiciones cerradas
18
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 21 (-2 vs trimestre anterior) | 18 (+5 vs trimestre anterior) | 33 (+2 vs trimestre anterior) | 25 (0 vs trimestre anterior) | +1.5M |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| BlackRock, Inc. | $13 865 957 | 2 988 353 | 15,88% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $10 059 822 | 2 168 065 | 11,52% | Acciones |
| VANGUARD GROUP INC | $9 521 608 | 2 288 848 | 10,91% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $6 072 509 | 1 308 394 | 6,96% | Acciones |
| OSAIC HOLDINGS, INC. | $5 585 280 | 1 203 725 | 6,40% | Acciones |
| MARSHALL WACE, LLP | $3 855 888 | 831 010 | 4,42% | Acciones |
| GREAT POINT PARTNERS LLC | $3 712 000 | 800 000 | 4,25% | Opción de compra |
| Wealthspire Advisors, LLC | $3 349 097 | 721 788 | 3,84% | Acciones |
| STATE STREET CORP | $2 634 495 | 567 779 | 3,02% | Acciones |
| COMMONWEALTH EQUITY SERVICES, LLC | $1 889 000 | 407 113 | 2,16% | Acciones |
| NORTHERN TRUST CORP | $1 793 569 | 386 545 | 2,05% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $1 700 449 | 366 476 | 1,95% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1 520 834 | 327 766 | 1,74% | Acciones |
| TWO SIGMA INVESTMENTS, LP | $1 476 657 | 318 245 | 1,69% | Acciones |
| LPL Financial LLC | $1 324 163 | 285 380 | 1,52% | Acciones |
| Geneos Wealth Management Inc. | $1 115 581 | 240 427 | 1,28% | Acciones |
| UBS Group AG | $1 017 641 | 219 319 | 1,17% | Acciones |
| CITADEL ADVISORS LLC | $981 824 | 211 600 | 1,12% | Opción de venta |
| RETIREMENT GUYS FORMULA LLC | $979 286 | 211 053 | 1,12% | Acciones |
| CITADEL ADVISORS LLC | $921 973 | 198 701 | 1,06% | Acciones |
| Sovran Advisors, LLC | $874 610 | 257 997 | 1,00% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $822 194 | 177 197 | 0,94% | Acciones |
| NATIONAL BANK OF CANADA /FI/ | $779 056 | 167 900 | 0,89% | Acciones |
| DEBUSSY CAPITAL MANAGEMENT LP | $721 449 | 258 584 | 0,83% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $700 640 | 151 000 | 0,80% | Opción de compra |
| BLAIR WILLIAM & CO/IL | $692 673 | 149 283 | 0,79% | Acciones |
| CITADEL ADVISORS LLC | $597 168 | 128 700 | 0,68% | Opción de compra |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $540 207 | 116 424 | 0,62% | Acciones |
| Bank of New York Mellon Corp | $490 644 | 105 742 | 0,56% | Acciones |
| HighTower Advisors, LLC | $436 740 | 94 125 | 0,50% | Acciones |
| MORGAN STANLEY | $433 724 | 93 475 | 0,50% | Acciones |
| SIMPLEX TRADING, LLC | $386 284 | 83 251 | 0,44% | Acciones |
| GOLDMAN SACHS GROUP INC | $345 931 | 74 554 | 0,40% | Acciones |
| TRUIST FINANCIAL CORP | $315 520 | 68 000 | 0,36% | Acciones |
| Nuveen, LLC | $295 614 | 63 710 | 0,34% | Acciones |
| BANK OF AMERICA CORP /DE/ | $267 798 | 57 715 | 0,31% | Acciones |
| RHUMBLINE ADVISERS | $224 257 | 48 332 | 0,26% | Acciones |
| DEUTSCHE BANK AG\ | $219 950 | 47 403 | 0,25% | Acciones |
| HORIZON KINETICS ASSET MANAGEMENT LLC | $217 932 | 46 968 | 0,25% | Acciones |
| WELLS FARGO & COMPANY/MN | $216 646 | 46 691 | 0,25% | Acciones |
| SYNOVUS FINANCIAL CORP | $203 280 | 48 000 | 0,23% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $201 112 | 43 343 | 0,23% | Acciones |
| Sanctuary Advisors, LLC | $193 627 | 41 730 | 0,22% | Acciones |
| Pinnacle Financial Partners, Inc. | $193 256 | 41 650 | 0,22% | Acciones |
| Caption Management, LLC | $185 600 | 40 000 | 0,21% | Opción de compra |
| JPMORGAN CHASE & CO | $184 825 | 37 188 | 0,21% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $166 404 | 35 863 | 0,19% | Acciones |
| Pekin Hardy Strauss, Inc. | $139 200 | 30 000 | 0,16% | Acciones |
| MetLife Investment Management, LLC | $133 980 | 28 875 | 0,15% | Acciones |
| Invesco Ltd. | $119 211 | 25 692 | 0,14% | Acciones |
Activistas y propietarios del %+ 5 5 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Richard E. Uihlein ×3 presentaciones | 4 de agosto de 2026 | 49,30% | Enmienda | Inversión pasiva | SEC |
| 10X Fund, L.P., 10X Capital Management, LLC, James C. Czirr ×15 presentaciones | 1 de diciembre de 2023 | · | Presentación inicial | Inversión pasiva | SEC |
| Rod D. Martin ×9 presentaciones | 18 de mayo de 2010 | · | Presentación inicial | · | SEC |
| James C. Czirr ×12 presentaciones | 17 de mayo de 2010 | · | Presentación inicial | · | SEC |
| 10X Fund, L.P. 10X Capital Management, LLC | 24 de marzo de 2009 | · | Presentación inicial | Inversión pasiva | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 41 insiders · 12 directivos · 28 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Joel Lewis | President and CEO | 16 de enero de 2026 A | 832 592 | 0 | 10 | $-620 880 |
| Peter G Traber | President & CEO | 13 de junio de 2018 M | 107 333 | 0 | 0 | $0 |
| David Platt | Chairman & CEO | 8 de octubre de 2008 P | 6 000 | 0 | 0 | $0 |
| Jack W Callicutt | Chief Financial Officer | 16 de enero de 2026 A | 7 614 | 0 | 20 | $-944 312 |
| Thomas Mcgauley | Chief Financial Officer | 19 de junio de 2013 A | 10 000 | 0 | 0 | $0 |
| Anthony Don Squeglia | Chief Financial Officer | 1 de febrero de 2010 A | · | 0 | 0 | $0 |
| Carl Laurence Lueders | Chief Financial Officer | 8 de marzo de 2007 A | · | 0 | 0 | $0 |
| David A Christopher | FORMER CFO & TREASURER | 14 de octubre de 2003 M | 17 729 | 0 | 0 | $0 |
| Maureen Foley | Chief Operating Officer | 1 de febrero de 2010 A | 5 000 | 0 | 0 | $0 |
| Khurram Jamil | Chief Medical Officer | 14 de julio de 2026 M | 0 | 0 | 17 | $-1 435 942 |
| Pol F Boudes | Chief Medical Officer | 24 de enero de 2024 A | · | 0 | 0 | $0 |
| Eliezer Zomer | Ex. VP, Mfg. & Product Dev. | 21 de abril de 2009 A | · | 0 | 0 | $0 |
| Richard E Uihlein | Consejero | 31 de julio de 2026 M | 44 713 843 | 0 | 0 | $0 |
| Harold H. Shlevin | Consejero | 29 de junio de 2026 M | 6 500 | 0 | 14 | $-1 555 866 |
| Henry Brem | Consejero | 12 de marzo de 2026 A | · | 0 | 0 | $0 |
| Kary Eldred | Consejero | 6 de febrero de 2026 P | 65 682 | 3 | 0 | $6 032 |
| Richard A. Zordani Jr. | Consejero | 16 de enero de 2026 A | 42 083 | 0 | 0 | $0 |
| Elissa J. Schwartz | Consejero | 16 de enero de 2026 A | 1 000 | 0 | 0 | $0 |
| Kevin D Freeman | Consejero | 16 de enero de 2026 A | 55 269 | 3 | 0 | $58 575 |
| Gilbert S Omenn | Consejero | 16 de enero de 2026 A | 66 769 | 0 | 0 | $0 |
| Gilbert F Amelio | Consejero | 16 de enero de 2026 A | 60 614 | 0 | 0 | $0 |
| Benjamin Carson SR | Consejero | 16 de enero de 2026 A | · | 0 | 0 | $0 |
| Marc Rubin | Consejero | 23 de enero de 2025 A | 13 581 | 0 | 0 | $0 |
| Stephen Shulman | Consejero | 16 de enero de 2019 A | · | 0 | 0 | $0 |
| Theodore Daniel Zucconi | Consejero | 16 de abril de 2018 M | 1 083 | 0 | 0 | $0 |
| John F Mauldin | Consejero | 15 de diciembre de 2016 A | 42 669 | 0 | 0 | $0 |
| Arthur Greenberg | Consejero | 15 de diciembre de 2016 A | 109 445 | 0 | 0 | $0 |
| Steven Prelack | Consejero | 15 de diciembre de 2016 A | 107 189 | 0 | 0 | $0 |
| Herman Paul Pressler | Consejero | 8 de abril de 2015 D | 36 767 | 0 | 0 | $0 |
| Rod D Martin | Consejero | 8 de abril de 2015 D | 202 089 | 0 | 0 | $0 |
| Jerald K Rome | Consejero | 28 de marzo de 2013 A | 22 058 | 0 | 0 | $0 |
| Sydney Colin Neill | Consejero | 28 de junio de 2011 A | · | 0 | 0 | $0 |
| Mildred S Christian | Consejero | 25 de febrero de 2009 A | 27 500 | 0 | 0 | $0 |
| Henry Jemil Esber | Consejero | 8 de febrero de 2009 A | · | 0 | 0 | $0 |
| James Theophile Gourzis | Consejero | 8 de febrero de 2009 A | 2 000 | 0 | 0 | $0 |
| Burton C Firtel | Consejero | 8 de marzo de 2007 A | 129 000 | 0 | 0 | $0 |
| David H Smith | Consejero | 8 de marzo de 2007 A | 63 500 | 0 | 0 | $0 |
| Edgar Ben-Josef | Consejero | 9 de marzo de 2006 A | · | 0 | 0 | $0 |
| James C Czirr | Propietario del 10% | 6 de junio de 2025 M | 1 045 541 | 0 | 0 | $0 |
| 10X Fund, L.P. | Propietario del 10% | 27 de julio de 2022 S | 6 168 940 | 0 | 0 | $0 |
| Dale H Conaway | · | 8 de febrero de 2009 A | 22 806 | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 11 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 164 297 SH | 11 de septiembre de 2026 | Diario |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 275 017 SH | 19 de agosto de 2026 | Diario |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 35 584 SH | 19 de agosto de 2026 | Diario |
| IWO · iShares Trust | 0,01% | 309 874 SH | 11 de septiembre de 2026 | Diario |
| IWM · iShares Trust | 0,01% | 1 042 597 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,00% | 22 888 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 595 153 SH | 19 de agosto de 2026 | Diario |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 521 443 SH | 19 de agosto de 2026 | Diario |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12 968 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 4 197 SH | 19 de agosto de 2026 | Diario |
| IWN · iShares Trust | · | 155 156 SH | 11 de septiembre de 2026 | Diario |
GALT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 7 analistas
COMPRA
Objetivo mediano
$11.00
+182,1%
2 28,6%
Compra fuerte
4 57,1%
Compra
1 14,3%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
1 analistas · 2026-10-02Objetivo medio $11.00 +182,1%
Mín$11.00
Media$11.00
Máx$11.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| GALT | $271M | -8.7 | · | · | 25.0% | · |
| TECX | $391M | -5.2 | · | · | -27.7% | · |
| SPRY | $1.16B | -6.7 | -5.5% | -203.3% | -111.8% | · |
| MYGN | $575M | -1.6 | -1.6% | -44.4% | -96.8% | 69.9% |
| KYTX | $568M | -2.6 | · | · | -77.4% | · |
| RZLT | $501M | -6.9 | · | · | -67.8% | · |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| CCCC | $185M | -1.5 | 1.0% | -292.1% | -48.8% | · |
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 14, 2026